Infection and Skin hypertrophy
Summary:
Skin hypertrophy is found among people with Infection, especially for people who are female, 50-59 old.
The study analyzes which people have Skin hypertrophy with Infection. It is created by eHealthMe based on reports of 13 people who have Infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Infection?
Infection is found to be associated with 2,504 drugs and 2,590 conditions by eHealthMe. Check the latest studies of Infection.
What is Skin hypertrophy?
Skin hypertrophy (skin cells enlarges) is found to be associated with 594 drugs and 544 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.
13 people who have Infection and Skin Hypertrophy are studied.

Gender of people who have Infection and experienced Skin Hypertrophy *:
- female: 76.92 %
- male: 23.08 %
Age of people who have Infection and experienced Skin Hypertrophy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 8.33 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 25.0 %
Common co-existing conditions for these people *:
- Anaemia (lack of blood): 8 people, 61.54%
- Pain: 5 people, 38.46%
- Stable Angina (a constant chest pain): 3 people, 23.08%
- Neck Pain: 3 people, 23.08%
- Nausea (feeling of having an urge to vomit): 3 people, 23.08%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 15.38%
- Diabetes: 2 people, 15.38%
- High Blood Pressure: 2 people, 15.38%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 7.69%
- Asthma: 1 person, 7.69%
Common drugs taken by these people *:
- Zemplar: 8 people, 61.54%
- Magnevist: 8 people, 61.54%
- Omniscan: 8 people, 61.54%
- Renagel: 7 people, 53.85%
- Multihance: 5 people, 38.46%
- Optimark: 5 people, 38.46%
- Protonix: 5 people, 38.46%
- Prohance: 5 people, 38.46%
- Sensipar: 5 people, 38.46%
- Neurontin: 5 people, 38.46%
Common symptoms for these people *:
- Skin Induration (an abnormally hard spot or area on the skin): 8 people, 61.54%
- Pain: 8 people, 61.54%
- Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 8 people, 61.54%
- Joint Range Of Motion Decreased (disease of joint movement): 8 people, 61.54%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 8 people, 61.54%
- Skin Discoloration: 7 people, 53.85%
- Muscle Tightness: 6 people, 46.15%
- Scar: 6 people, 46.15%
- Gait Disturbance: 6 people, 46.15%
- Oedema Peripheral (superficial swelling): 5 people, 38.46%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Skin hypertrophy?
- Check whether Skin hypertrophy is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Infection (201,697 reports)
- Skin hypertrophy (4,077 reports)
All the drugs that are associated with Skin hypertrophy:
- Skin hypertrophy (594 drugs)
All the conditions that are associated with Skin hypertrophy:
- Skin hypertrophy (544 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Skin hypertrophy and Infection, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Actos and Nevanac - 2 seconds ago
- Back Pain and Nausea And Vomiting - 10 seconds ago
- Immunodeficiency Disorders and Hepatic Function Abnormal - 13 seconds ago
- Could Solu-Medrol cause Sinus Arrhythmia? - 14 seconds ago
- Could Acetaminophen And Hydrocodone Bitartrate cause Pneumothorax? - 15 seconds ago
- Ill-Defined Disorder and Hepatic Failure - 16 seconds ago
- Idiopathic Pulmonary Fibrosis and Throat Irritation - 20 seconds ago
- Could Codeine cause Numbness And Tingling? - 21 seconds ago
- Drug interactions of Micardis and Exjade - 27 seconds ago
- Could Wellbutrin cause Guillain-Barre Syndrome? - 27 seconds ago